Brookstone Capital Management Repligen Corp Transaction History

Brookstone Capital Management

  • $5.98 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 14, 2021
SELL
$165.87 - $220.95 $307,522 - $409,641
-1,854 Closed
0 $0
Q1 2021

Apr 16, 2021
SELL
$180.37 - $226.26 $313,122 - $392,787
-1,736 Reduced 48.36%
1,854 $360,000
Q4 2020

Jan 13, 2021
BUY
$148.08 - $206.57 $531,607 - $741,586
3,590 New
3,590 $688,000

Others Institutions Holding RGEN

# of Institutions
479
Shares Held
54.9M
Call Options Held
297K
Put Options Held
343K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email